Category Archives: Wholesale Pharmacy

Warning: include() [function.include]: Failed opening '../zinc/fetchad.php' for inclusion (include_path='.:/usr/lib/php:/usr/local/lib/php') in /home/slyckco/public_html/forums/includes/functions.php on line 4586 Warning: Cannot modify header information - headers already sent by (output started at /home/slyckco/public_html/forums/includes/functions.php:4586) in /home/slyckco/public_html/forums/includes/functions.php on line 4725 Warning: Cannot modify header information - headers already sent by (output started at /home/slyckco/public_html/forums/includes/functions.php:4586) in /home/slyckco/public_html/forums/includes/functions.php on line 4727 Warning: Cannot modify header information - headers already sent by (output started at /home/slyckco/public_html/forums/includes/functions.php:4586) in /home/slyckco/public_html/forums/includes/functions.php on line 4728 Warning: Cannot modify header information - headers already sent by (output started at /home/slyckco/public_html/forums/includes/functions.php:4586) in /home/slyckco/public_html/forums/includes/functions.php on line 4729 You have been permanently banned from this board. Please contact the Board Administrator for more information. A ban has been issued on your IP address. See original here: First Amendment in the Digital Age: How Copyright Enforcement Is Threatening Free Speech Online And How The ... … Continue reading →

Washington, DC (PRWEB) June 13, 2013 Atlantic Information Services, Inc. (AIS), publishers of industry-leading newsletters Drug Benefit News and Specialty Pharmacy News, is pleased to announce the release of Drug Benefit Trends and Strategies: 2013, a brand-new resource containing valuable insight and expert analysis on pharmacy benefit management trends in regards to market share, formulary structures, PBM contracting, transparency, copays and Rx drug costs, and utilization. Available in a printed book or CD format, this well-organized resource serves as an Executive Summary of pharmacy benefits corporate activity with details of financial results, leadership changes, enrollment statistics, and mergers and acquisitions activity including a look at the impact of the Express Scripts-Medco merger. Drug Benefit Trends and Strategies: 2013 provides convenient access to analysis by industry experts and thought leaders from across the nation to help answer vital questions such as: Additionally, Drug Benefit Trends and Strategies: 2013 includes a completely updated directory of pharmacy benefit vendors, with addresses, company phone numbers, websites and top executive names and titles. Drug Benefit Trends and Strategies: 2013 was written for professionals at PBMs, PBAs and SPPs, pharmacies and drug stores, pharmaceutical companies and manufacturers, health plans, pharmaceutical research organizations, health systems and medical … Continue reading →

Walgreens has agreed to pay a record-breaking $80 million penalty to resolve a U.S. Drug Enforcement Administration investigation into the company's dispensing practices in Florida, including at an Oviedo pharmacy. The DEA in September banned a Walgreens distribution center in Jupiter from dispensing controlled substances to its pharmacies in Florida and the East Coast, saying it was the single-largest distributor of oxycodone in the state. The top six Walgreens pharmacies in Florida were also targeted in the probe, including the store on Lockwood Boulevard. In addition to the penalty, the DEA also said in its settlement made public Tuesday that the Walgreens distribution center and six stores are banned from dispensing Schedule II through Schedule V drugs until 2014, which include the painkillers OxyContin, Percocet and Vicodin, and the sedative Xanax. "National pharmaceutical chains are not exempt from following the law," said DEA Special Agent in Charge Mark R. Trouville in a prepared statement. "This settlement sends out a clear message that all DEA registrants will be held accountable when they violate the law and threaten public health and safety," he said. "The DEA will continue its efforts to work with our registrants and our law enforcement partners to combat … Continue reading →

Walgreens has agreed to pay a record-breaking $80 million penalty to resolve a U.S. Drug Enforcement Administration investigation into the company's dispensing practices in Florida, including at an Oviedo pharmacy. The DEA in September banned a Walgreens distribution center in Jupiter from dispensing controlled substances to its pharmacies in Florida and the East Coast, saying it was the single-largest distributor of oxycodone in the state. The top six Walgreens pharmacies in Florida were also targeted in the probe, including the store on Lockwood Boulevard. In addition to the penalty, the DEA also said in its settlement made public Tuesday that the Walgreens distribution center and six stores are banned from dispensing Schedule II through Schedule V drugs until 2014, which include the painkillers OxyContin, Percocet and Vicodin, and the sedative Xanax. "National pharmaceutical chains are not exempt from following the law," said DEA Special Agent in Charge Mark R. Trouville in a prepared statement. "This settlement sends out a clear message that all DEA registrants will be held accountable when they violate the law and threaten public health and safety," he said. "The DEA will continue its efforts to work with our registrants and our law enforcement partners to combat … Continue reading →

(Memphis) Officials with the Centers for Disease Control and Prevention now say there are 24 reported cases associated with suspect steroid injections made and shipped from Main Street Family Pharmacy in Dyer County. Thats up from 20 last week. The agency updated a page on its website late Monday that keeps track of whats now being called an outbreak. More than a week ago, information surfaced that revealed Main Street had shipped possibly tainted steroid injections to medical facilities in several states. The pharmacy has since voluntarily recalled more than 300 products. History of Problems for Main Street As federal and state health authorities search for the source of the problem, theres a national push for more regulation over compounding pharmacies. So what does that mean for the average consumer and their safety? It may sound fancy, but compounding pharmacies have been around for hundreds of years. Youre taking multiple ingredients and combining that into a product for the patient, explains Brett Wright, who runs Benevere Pharmacy in Collierville. Think of the days when your grandma got sick. There werent always pain medicines on shelf, so the pharmacist created something. Fast forward to today, and places like that still exist. … Continue reading →

The country's medicines and medical devices safety authority has recalled a skin bleach banned in the European Union that's been linked with cancer in lab rats. Medsafe has instructed the distributor to pull products containing the controversial skin whitener, hydroquinone, from wholesale and retail outlets. An investigation by the Sunday Star-Times in April highlighted sales of the drug may be breaching medicines regulations. The medicine had been sold inadvertently over the counter by national beauty chain Caci since 2004, as well as by Trade Me. While hydroquinone is classified as a pharmacy-only medicine, Medsafe said last month no products containing the drug had been approved for sale here. Medsafe compliance management branch manager Derek Fitzgerald said popular pharmacy brand John Plunkett's Superfade was included in the recall. "They are no longer supplying Superfade. But there could still be Superfade in the retail chains at the moment. If it hasn't already happened, it will happen shortly." Superfade has been sold in New Zealand for about 15 years. There have been no reported adverse reactions to its use here and marketer Pharmabroker Sales, which started marketing and distributing the product late last year, said it was growing in popularity. Pharmabroker Sale's Warren … Continue reading →

FLORHAM PARK, N.J., May 31, 2013 /PRNewswire/ -- Armada Health Care (Armada), the nation's largest group purchasing and channel management organization for the Specialty Pharmacy market, is pleased to appoint Mike Baldzicki as Executive Vice President of Industry Relations & Advocacy. In his new role, Mr. Baldzicki will implements strategic business development to cultivate opportunities to speak/present on pertinent industry topics that affect Armada and its client base at industry events within key market sectors for specialty pharmacy. Armada Health Care is leading the specialty pharmacy industry with channel management solutions, commercialization strategies and specialty pharmacy support services. With more than 14 years of pharmaceutical and biotech industry experience, including roles in national and regional managed markets, specialty supply channels, sales management and specialty brand management, Mr. Baldzicki offers strategic insight into specialty pharmacy trends, distribution, contracting, reimbursement, and the application of health outcomes and economic evidence to prove value proposition. He is a recognized leader in the specialty pharmaceutical market for developing and implementing key payer and specialty pharmacy agreements that result in documented savings for specialty market segments. Mr. Baldzicki is active in the biotech community and is a member of the Academy of Managed Care Pharmacy (AMCP), … Continue reading →

By Mark Lin - May 28, 2013 | Tickers: COST, SPTN, WMT | 0 Comments Mark is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited. I was on the lookout for market leaders in niche markets and I came across Spartan Stores (NASDAQ: SPTN), the largest regional supermarket chain and distributor in Michigan. While Spartan Stores faces stiff competition from supercenters, it is meeting the challenge head-on with its new value store format, focusing on budget conscious shoppers. Furthermore, it is also witnessing growth in its wholesale distribution business outside of Michigan. Spartan Stores is valued at a discount to its peers, and will be an ideal contrarian pick for those who believe that local supermarket chains can stop the supercenter juggernaut. New value store format could be a game-changer Good locations and a wide variety of products at affordable prices are now taken for granted by shoppers. Spartan Stores opened its first value store,Valu Land, in the first quarter of fiscal 2013, and currently has seven stores with three more in the pipeline. Valu Land was set up to exploit budget shoppers dissatisfaction with dollar … Continue reading →

SILVER SPRING, Md., May 23, 2013 /PRNewswire/ -- Pharmagen, Inc. (PHRX) (the "Company" or "Pharmagen") announced today that Mackie A. Barch, CEO, will present at the Second Annual Marcum LLP MicroCap Conference on Thursday, May 30, 2013 in New York City at the Grand Hyatt Hotel. The Company's presentation is scheduled to begin at 2:30 p.m. EDT and will be available via a live webcast. For more information and registration, please visit the conference website: http://www.marcumllp.com/microcap About Pharmagen Pharmagen, Inc. ("Pharmagen"), and wholly owned subsidiaries and operating divisions Pharmagen Laboratories, Inc., Pharmagen Distribution, LLC and Pharmagen Nutraceuticals, Inc. is the leader in innovative solutions to the nations sterile pharmaceutical crisis. With a multifaceted approach, Pharmagen is meeting the demand of health provider market through dynamic, independent wholesale, compounding, and innovative IT solutions. Nationally focused, Pharmagen is a dynamic distributor of specialty drugs, compounding and admix pharmacy and producer of over-the-counter ("OTC") branded multivitamins to the healthcare provider market. Pharmagen currently functions as a just-in-time source of supply for hospitals for those products that are hard-to-find due to drug manufacturers' production shortages. About Marcum LLP Marcum LLP is one of the largest independent public accounting and advisory services firms in the … Continue reading →

A U.S. Senate committee on Wednesday passed bipartisan legislation that would fundamentally change how large-scale pharmacy compounding is practiced in this country. Also Wednesday, the Senates Health, Education, Labor and Pensions Committee issued a report showing that poor compounding practices have persisted even since last fall, when a meningitis outbreak linked to contaminated steroid injections killed 55 people and sickened about 700. Sen. Pat Roberts of Kansas urged senators to support the bill, noting that the report showed the status quo is unacceptable. Saying that the current law is satisfactory or preferable to anything we might do is nonsense, Roberts said. Fifty-five people have died. The compounding bill now goes to the Senate floor for consideration in June or July. The bill is the first piece of federal legislation to require stricter regulation of compounding since Kansas City pharmacist Robert Courtney pleaded guilty a decade ago, admitting that he had diluted thousands of doses of chemotherapy medication. The Kansas City Star first exposed concerns about the safety of compounded drugs in a 2002 series. Compounding is a traditional part of pharmacy practice in which pharmacists create customized medications from scratch, but without having to meet the same safety and quality … Continue reading →